Mondor's disease
Mondor's disease | |
ICD-10 | I80.8 (ILDS I80.81) |
---|---|
ICD-9 | 451.89 |
DiseasesDB | 32183 |
eMedicine | derm/909 |
WikiDoc Resources for Mondor's disease |
Articles |
---|
Most recent articles on Mondor's disease Most cited articles on Mondor's disease |
Media |
Powerpoint slides on Mondor's disease |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Mondor's disease at Clinical Trials.gov Trial results on Mondor's disease Clinical Trials on Mondor's disease at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Mondor's disease NICE Guidance on Mondor's disease
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Mondor's disease Discussion groups on Mondor's disease Patient Handouts on Mondor's disease Directions to Hospitals Treating Mondor's disease Risk calculators and risk factors for Mondor's disease
|
Healthcare Provider Resources |
Causes & Risk Factors for Mondor's disease |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Mondor's disease is a rare condition which involves thrombophlebitis of the superficial veins of the breast and anterior chest wall. It sometimes occurs in the arm or penis.
Historical Perspective
It is named after Henri Mondor (1885-1962), a surgeon in Paris, France who first described the disease in 1939.
Differentiating Mondor's Disease from other Diseases
Mondor's disease must be differentiated from other diseases that cause breast pain and swelling.
ABBREVIATIONS
LAP=Lymphadenopathy, HRT=Hormonal replacement therapy, FNA=Fine needle aspiration, DCIS=Ductal carcinoma in-situ
Diseases | Benign or
Malignant |
Clinical manifestation | Paraclinical findings | Gold standard diagnosis | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | Histopathology | Imaging | ||||||||
Mass | Mastalgia | Nipple discharge | Breast exam | Skin changes | LAP | ||||||||
Fibroadenoma |
|
+ | ± | – |
|
– | – | Ultrasound:
|
|||||
Breast cyst |
|
|
|
+ | ± | – |
|
– | – |
|
Ultrasound: | ||
Fibrocystic change |
|
|
|
+ | + | ± | – | – |
|
Ultrasound: |
| ||
Galactocele |
|
|
+ | ± | ± |
|
– | – |
|
Mammography:
|
|||
Cysts of montgomery |
|
|
|
+ | ± | ± |
|
± | – |
|
Ultrasound:
|
||
Hamartoma |
|
|
|
± | – | – |
|
± | – |
|
Mammography:
|
||
Breast abscess |
|
|
+ | + | – |
|
+ | – |
|
Ultrasound:
|
|||
Mastitis |
|
|
|
± | + | ± |
|
+ | – | Breast parenchyma inflammation: | Ultrasound:
|
||
Diseases | Benign or Malignant |
Demography | History | Mass | Mastalgia | Nipple discharge | Breast exam | Skin changes | LAP | Histopathology | Imaging | Gold standard diagnosis | |
Breast carcinoma |
|
|
+ | – | ± |
|
± | ± | Mammography:
|
||||
Ductal carcinoma in situ (DCIS) |
|
|
± | – | ± |
|
– | – |
|
Mammography:
|
|||
Microinvasive breast cancer |
|
|
+ | – | ± |
|
– | ± |
|
Mammography:
|
|||
Breast sarcoma |
|
|
+ | – | – |
|
± | – |
|
Mammography:
|
|||
Phyllodes tumor |
|
|
± | – | – |
|
– | – |
|
Ultrasound:
|
|||
Lymphoma |
|
|
+ | – | – |
|
– | ± |
|
Mammography:
|
| ||
Duct ectasia |
|
|
± | ± | ± |
|
– | – |
|
Ultrasound:
|
|||
Intraductal papilloma |
|
+ | ± | ± |
|
– | – |
|
Ultrasound:
|
| |||
Lipoma |
|
|
+ | – | – |
|
– | – |
|
Ultrasound:
|
|||
Sclerosing adenosis |
|
|
|
± | + | – |
|
± | – |
|
Mammography:
|
||
Pseudoangiomatous stromal hyperplasia |
|
|
+ | – | – |
|
– | – |
|
Mammography and ultrasound:
|
|||
Mondor's disease |
|
+ | + | – |
|
+ | – |
|
Ultrasound:
|
| |||
Diseases | Benign or Malignant |
Demography | History | Mass | Mastalgia | Nipple discharge | Breast exam | Skin changes | LAP | Histopathology | Imaging | Gold standard diagnosis | |
Diabetic mastopathy |
|
|
+ | – | – |
|
– | – |
|
Ultrasound:
|
| ||
Gynecomastia |
|
|
+ | ± | ± |
|
– | – |
|
Ultrasound: | |||
Sarcoidosis |
|
|
+ | – | – |
|
– | – |
|
Mammography:
|
|||
Fat necrosis |
|
+ | ± | – |
|
– | – |
|
Ultrasound:
|